Fixed Price IPO | ₹10 Cr | Listed at BSE SME | Fri, Jan 31, 2020 - Thu, Feb 6, 2020
Chandra Bhagat Pharma IPO is a fixed price issue of ₹10.20 crores. The issue is entirely a fresh issue of 0.20 crore shares of ₹10.20 crore.
Chandra Bhagat Pharma IPO bidding started from Jan 31, 2020 and ended on Feb 6, 2020. The allotment for Chandra Bhagat Pharma IPO was finalized on Feb 11, 2020. The shares got listed on BSE SME on Feb 14, 2020.
Chandra Bhagat Pharma IPO price is ₹51 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,02,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,04,000.
Beeline Broking Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Beeline Broking Ltd..
Refer to Chandra Bhagat Pharma IPO RHP for detailed Information.
IPO Open
Fri, Jan 31, 2020
IPO Close
Thu, Feb 6, 2020
Issue Price
₹51 per share
Market Cap (Pre-IPO)
₹38.48 Cr
| IPO Date | 31 Jan to 6 Feb, 2020 |
| Listed on | Fri, Feb 14, 2020 |
| Face Value | ₹10 per share |
| Issue Price | ₹51 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 20,00,000 shares (agg. up to ₹10 Cr) |
| Reserved for Market Maker | 1,00,000 shares Beeline Broking Ltd. (agg. up to ₹0.5100 Cr) |
| Fresh Issue (Ex Market Maker) | 19,00,000 shares (agg. up to ₹10 Cr) |
| Net Offered to Public | 19,00,000 shares (agg. up to ₹10 Cr) |
| Share Holding Pre Issue | 55,45,056 shares |
| Share Holding Post Issue | 75,45,056 shares |
| BSE Script Code | 542934 |
| ISIN | INE07QQ01016 |
Chandra Bhagat Pharma IPO comprises a total issue size of 20,00,000 shares. The net offer to the public is 19,00,000 shares, after excluding 1,00,000 shares allotted on a firm basis. Of the Net offer 9,50,000 (50.00%) allocated to NII 9,50,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 9,50,000 | 50.00% | 47.50% |
| Retail Shares Offered | 9,50,000 | 50.00% | 47.50% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,00,000 | 5.00% | |
| Total Shares Offered | 20,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,02,000 |
| Retail (Max) | 1 | 2,000 | ₹1,02,000 |
| HNI (Min) | 2 | 4,000 | ₹2,04,000 |
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.
The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.
Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.
Competitive Strengths
1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Incremental Working Capital Requirements | 7.00 |
| 2 | Setting up Distribution and Warehousing Centre’s | 1.50 |
| 3 | General Corporate Purpose | 0.95 |
| 4 | To meet Public Issue Expenses | 0.75 |
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 51 | |
| Promoter Holding | 96.72% | 71.08% |
| Market Cap | ₹38.48 Cr. |
The CBC Pharma IPO is subscribed 1.65 times on February 6, 2020 6:45:03 PM (Day 5). The public issue subscribed 1.44 times in the retail category, [.] times in the QIB category, and 1.87 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 1.87 | 9,50,000 | 17,78,000 |
| Retail | 1.44 | 9,50,000 | 13,66,000 |
| Total | 1.65 | 19,00,000 | 31,44,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees including Underwriting Commission | 0.18 |
| 2 | Fees Payable to Registrar to the Issue | 0.01 |
| 3 | Fees Payable for Marketing and Advertisement Expenses | 0.38 |
| 4 | Fees Payable to Regulators including Stock Exchanges | 0.03 |
| 5 | Payment for Printing and Distribution of Issue Stationaries | 0.01 |
| 6 | Others (Fees Payable to Peer Review Auditor, Fees to Legal Advisors, Marketing Expenses, Custodians Fees, Market Making, Brokerage, Processing Fees for Application and Miscellaneous Expenses) | 0.14 |
| 7 | Processing Fees to SCSBs for ASBA Application Procured by the Members of the Syndicate or Registered Brokers and Submitted with SCSB’s | 0.00 |
| 8 | Processing Fees Issued to Issuer Bank for UPI Mechanism w.r.t. Application forms procured by the members of the Syndicate, Registered Brokers, RTAs or the CDP’s and submitted to them | 0.00 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹51.00 |
| Open | ₹51.70 |
| Low | ₹51.00 |
| High | ₹52.10 |
| Last Trade | ₹51.75 |
Lead Manager Reports
Chandra Bhagat Pharma IPO is a SME IPO of 20,00,000 equity shares of the face value of ₹10 aggregating up to ₹10 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000.
The IPO opens on Fri, Jan 31, 2020, and closes on Thu, Feb 6, 2020.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Chandra Bhagat Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Chandra Bhagat Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Chandra Bhagat Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Chandra Bhagat Pharma IPO opens on Fri, Jan 31, 2020 and closes on Thu, Feb 6, 2020.
Chandra Bhagat Pharma IPO lot size is 2000, and the minimum amount required for application is ₹1,02,000.
You can apply in Chandra Bhagat Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Chandra Bhagat Pharma IPO will be done on Tuesday, February 11, 2020, and the allotted shares will be credited to your demat account by Thu, Feb 13, 2020. Check the Chandra Bhagat Pharma IPO allotment status.
The Chandra Bhagat Pharma IPO listing date is on Fri, Feb 14, 2020.
